The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
February 1, 2015|
A chemical engineer walks into a biology lab . . . and revolutionizes bioengineering. How Robert Langer blazed a trail in drug delivery and regenerative medicine.